{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:55:55Z","timestamp":1781337355540,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["1802220N"],"award-info":[{"award-number":["1802220N"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["BOF\/GOA\/023"],"award-info":[{"award-number":["BOF\/GOA\/023"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["1803816N"],"award-info":[{"award-number":["1803816N"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SE7225N"],"award-info":[{"award-number":["1SE7225N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.scr.2025.103864","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:13:44Z","timestamp":1761783224000},"page":"103864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Generation and characterization of three human induced pluripotent stem cell lines (UGENTi005, UGENTi006 and UGENTi007) from patients with autosomal dominant adult-onset maculopathy due to RPE65 variant c.1555G>A, p.(E519K)"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-1199","authenticated-orcid":false,"given":"Eline","family":"Van Vooren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van den Broeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Daal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Ghazvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"De Zaeytijd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart P.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Bauwens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-6895","authenticated-orcid":false,"given":"Elfride","family":"De Baere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scr.2025.103864_b0005","first-page":"400","article-title":"Prevalence and genetic characteristics of RPE65-associated retinal disease","volume":"60","author":"Alastalo","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.scr.2025.103864_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2025.103739","article-title":"Generation of two iPSC lines (UGENTi003 and UGENTi004) from patients with intermediate rod-cone dystrophy carrying the c.[-123C>T;701G>A];[806_810del] variants in the RDH12 gene","volume":"86","author":"Bouckaert","year":"2025","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.scr.2025.103864_b0015","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ejhg.2011.86","article-title":"A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement","volume":"19","author":"Bowne","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.scr.2025.103864_b0020","first-page":"3122","article-title":"In-depth phenotypic study of a novel autosomal dominant RPE65-related retinal dystrophy","volume":"66","author":"Van den Broeck","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.scr.2025.103864_b0025","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddy128","article-title":"Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65","volume":"27","author":"Choi","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.scr.2025.103864_b0030","doi-asserted-by":"crossref","unstructured":"da Costa BL, Caruso SM, Tsai Y-T, Castillejos DS, Sylla M, Tsang SH, et al. Prime Editing Strategy to Install the RPE65 c.1430A>G Dominant Mutation. In: Bowes Rickman C, Grimm C, Anderson RE, Ash JD, Pierce E, Hollyfield JG, editors. Retinal Degenerative Diseases XX, Cham: Springer Nature Switzerland; 2025, p. 101\u20136.","DOI":"10.1007\/978-3-031-76550-6_17"},{"key":"10.1016\/j.scr.2025.103864_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101665","article-title":"Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)","volume":"43","author":"Ding","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.scr.2025.103864_b0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ng1097-194","article-title":"Mutations in RPE65 cause autosomal recessive childhood\u2013onset severe retinal dystrophy","volume":"17","author":"Gu","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.scr.2025.103864_b0045","first-page":"626","article-title":"The clinical features of retinal disease due to a dominant mutation in RPE65","volume":"22","author":"Hull","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.scr.2025.103864_b0050","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a004952","article-title":"Phenotypic expansion of autosomal dominant retinitis pigmentosa associated with the D477G mutation in RPE65","volume":"6","author":"Jauregui","year":"2020","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"10.1016\/j.scr.2025.103864_b0055","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/13816810.2018.1484929","article-title":"Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa","volume":"39","author":"Jauregui","year":"2018","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.scr.2025.103864_b0060","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt958","article-title":"The database of genomic variants: a curated collection of structural variation in the human genome","volume":"42","author":"MacDonald","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.scr.2025.103864_b0065","doi-asserted-by":"crossref","unstructured":"Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma J-X. RPE65 is the isomerohydrolase in the retinoid visual cycle. 2005.","DOI":"10.1073\/pnas.0503460102"},{"key":"10.1016\/j.scr.2025.103864_b0070","doi-asserted-by":"crossref","first-page":"13658","DOI":"10.1073\/pnas.0504167102","article-title":"Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle","volume":"102","author":"Redmond","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.scr.2025.103864_b0075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/3813","article-title":"Rpe65 is necessary for production of 11-cis-vitamin a in the retinal visual cycle","volume":"20","author":"Redmond","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.scr.2025.103864_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113800","article-title":"ViVar: A comprehensive platform for the analysis and visualization of structural genomic variation","volume":"9","author":"Sante","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.scr.2025.103864_b0085","first-page":"4293","article-title":"Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration","volume":"41","author":"Thompson","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.scr.2025.103864_b0090","doi-asserted-by":"crossref","unstructured":"Van Vooren E, Van den Broeck F, Mahieu Q, Geens E, Van Heetvelde M Van, Bruyne M De, et al. RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals. Invest Ophthalmol Vis Sci 2025;66:53\u201353. https:\/\/doi.org\/10.1167\/IOVS.66.12.53.","DOI":"10.1167\/iovs.66.12.53"},{"key":"10.1016\/j.scr.2025.103864_b0095","doi-asserted-by":"crossref","unstructured":"Wu W, Takahashi Y, Younghwa Shin H, Ma X, Moiseyev G, Ma J-X, et al. The interplay of environmental luminance and genetics in the retinal dystrophy induced by the dominant RPE65 mutation 2022. https:\/\/doi.org\/10.1073\/pnas.","DOI":"10.1073\/pnas.2115202119"}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506125002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506125002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:15:53Z","timestamp":1781334953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506125002144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":19,"alternative-id":["S1873506125002144"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2025.103864","relation":{},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of three human induced pluripotent stem cell lines (UGENTi005, UGENTi006 and UGENTi007) from patients with autosomal dominant adult-onset maculopathy due to RPE65 variant c.1555G>A, p.(E519K)","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2025.103864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103864"}}